Skip to main content

Table 1 Runx2, Alp and Ocn expressions in day 3 samples (fold-change in gene expression)

From: Rapid cell culture and pre-clinical screening of a transforming growth factor-β (TGF-β) inhibitor for orthopaedics

(A) Runx2 expression in day 3 samples (fold-change in gene expression)

 

0 μM SB431542

5 μM SB431542

no BMP-2/TGF-β1

1.00 (0.11)

1.77 (0.15)

50 ng/ml BMP-2

1.62 (0.10)

3.59 (0.34)

5 ng/ml TGF-β1

0.54 (0.10)

2.01 (0.09)

50 ng/ml BMP-2, 5 ng/ml TGF-β1

0.56 (0.12)

2.05 (0.23)

(B) Alp expression in day 3 samples (fold-change in gene expression)

 

0 μM SB431542

5 μM SB431542

no BMP-2/TGF-β1

1.00 (0.13)

3.51 (0.25)

50 ng/ml BMP-2

5.50 (1.25)

11.05 (0.29)

5 ng/ml TGF-β1

0.15 (0.04)

0.92 (0.08)

50 ng/ml BMP-2, 5 ng/ml TGF-β1

0.27 (0.05)

3.47 (0.38)

(C) Ocn expression in day 10 samples (fold-change in gene expression)

 

0 μM SB431542

5 μM SB431542

no BMP-2/TGF-β1

1.00 (0.06)

1.45 (0.25)

50 ng/ml BMP-2

4.11 (0.28)

5.18 (0.34)

5 ng/ml TGF-β1

0.06 (0.01)

0.70 (0.03)

50 ng/ml BMP-2, 5 ng/ml TGF-β1

0.69 (0.06)

3.72 (0.06)